These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 7920441

  • 1. Biochemical studies of inherited diseases related to abnormal cholesterol metabolism. I. High-performance liquid chromatographic analysis of bile alcohol glucuronides in cerebrotendinous xanthomatosis.
    Ohshima A, Kuramoto T, Hoshita T.
    Biol Pharm Bull; 1994 May; 17(5):721-3. PubMed ID: 7920441
    [Abstract] [Full Text] [Related]

  • 2. Increased plasma bile alcohol glucuronides in patients with cerebrotendinous xanthomatosis: effect of chenodeoxycholic acid.
    Batta AK, Salen G, Shefer S, Tint GS, Batta M.
    J Lipid Res; 1987 Aug; 28(8):1006-12. PubMed ID: 3668385
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Serum bile acid profiles in cerebrotendinous xanthomatosis.
    Beppu T, Seyama Y, Kasama T, Serizawa S, Yamakawa T.
    Clin Chim Acta; 1982 Feb 05; 118(2-3):167-75. PubMed ID: 7055978
    [Abstract] [Full Text] [Related]

  • 9. Determination of the glucurono-conjugated position in bile alcohol glucuronides excreted in urine of a patient with cerebrotendinous xanthomatosis by a nuclear magnetic resonance study.
    Kuramoto T, Fukuda K, Ohshima A, Kihira K, Hoshita T.
    J Biochem; 1994 Apr 05; 115(4):655-8. PubMed ID: 8089079
    [Abstract] [Full Text] [Related]

  • 10. Bile alcohol profiles in bile, urine, and feces of a patient with cerebrotendinous xanthomatosis.
    Shimazu K, Kuwabara M, Yoshii M, Kihira K, Takeuchi H, Nakano I, Ozawa S, Onuki M, Hatta Y, Hoshita T.
    J Biochem; 1986 Feb 05; 99(2):477-83. PubMed ID: 3700361
    [Abstract] [Full Text] [Related]

  • 11. Stable isotope dilution assay for 5 beta-cholestane-3 alpha,7 alpha,12 alpha,25-tetrol and 5 beta-cholestane-3 alpha,7 alpha,12 alpha,23,25-pentol in human serum using [26,27-D6] labeled internal standards; a highly accurate approach to the serological diagnosis of cerebrotendinous xanthomatosis.
    Kosaka D, Hiraoka T, Kohoda T, Kajiyama G, Yamauchi T, Kihira K, Kuramoto T, Hoshita T.
    Clin Chim Acta; 1991 May 31; 199(1):83-9. PubMed ID: 1934504
    [No Abstract] [Full Text] [Related]

  • 12. Identifications of 5 beta-cholestane-3 alpha, 7 alpha, 12 alpha, 23 beta-tetrol, 5 beta-cholestane-3 alpha, 7 alpha, 12 alpha, 24 alpha-tetrol, and 5 beta-cholestane-3 alpha, 7 alpha, 12 alpha, 24 beta-tetrol in cerebrotendinous xanthomatosis.
    Yasuhara M, Kuramoto T, Hoshita T, Itoga E, Kito S.
    Steroids; 1978 Mar 31; 31(3):333-45. PubMed ID: 663972
    [Abstract] [Full Text] [Related]

  • 13. Simplified determination of cholestanol in serum by gas-liquid chromatography: biochemical diagnosis of cerebrotendinous xanthomatosis.
    Serizawa S, Seyama Y, Otsuka H, Kasama T, Yamakawa T.
    J Biochem; 1981 Jul 31; 90(1):17-21. PubMed ID: 7287675
    [Abstract] [Full Text] [Related]

  • 14. Quantitative analysis of sterols in serum by high-performance liquid chromatography. Application to the biochemical diagnosis of cerebrotendinous xanthomatosis.
    Kasama T, Byun DS, Seyama Y.
    J Chromatogr; 1987 Jul 29; 400():241-6. PubMed ID: 3667750
    [Abstract] [Full Text] [Related]

  • 15. Bile alcohol glucuronides: regioselective O-glucuronidation of 5 beta-cholestane-3 alpha,7 alpha,12 alpha,25-tetrol and 24-nor-5 beta-cholestane-3 alpha,7 alpha,12 alpha,25-tetrol.
    Dayal B, Salen G, Padia J, Shefer S, Tint GS, Sasso G, Williams TH.
    Carbohydr Res; 1993 Feb 24; 240():133-42. PubMed ID: 8458007
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effect of chenodeoxycholic acid on biliary and urinary bile acids and bile alcohols in cerebrotendinous xanthomatosis; monitoring by high performance liquid chromatography.
    Batta AK, Shefer S, Batta M, Salen G.
    J Lipid Res; 1985 Jun 24; 26(6):690-8. PubMed ID: 4031647
    [Abstract] [Full Text] [Related]

  • 19. Biochemical abnormalities in cerebrotendinous xanthomatosis.
    Salen G, Shefer S, Berginer V.
    Dev Neurosci; 1991 Jun 24; 13(4-5):363-70. PubMed ID: 1817043
    [Abstract] [Full Text] [Related]

  • 20. Reduction of urinary bile alcohol excretion and serum cholestanol in patients with cerebrotendinous xanthomatosis after oral administration of deoxycholic acid.
    Wolthers BG, van der Molen JC, Walrecht H, Hesselmans LF.
    Clin Chim Acta; 1990 Dec 14; 193(3):113-8. PubMed ID: 2282689
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.